Vivoryon also presented a poster at the World Congress of Nephrology (WCN) in Yokohama, Japan on March 28, 2026, providing an update on the growing body of evidence validating glutaminyl cyclases ...

This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...

Tuesday, May 6, 2025 at 8:30 a.m. ET Michael Stein said, "the year over year comparative results for our retail energy ...

Group sales were +6% at constant exchange rates (CER)1, -5% when reported in CHF and +9% in USD2, in the first three months, ...

The new GLB is a significant step forward over its EQB predecessor, offering seven-seat practicality, cutting-edge technology ...

There’s a general consensus that too much screen time is bad for kids. But what happens when everything in modern society is ...

I'd like to welcome you to IBM's First Quarter 2026 Earnings Presentation. I'm Olympia McNerney, and I'm here today with Arvind Krishna, IBM's Chairman, President and Chief Executive Officer; and Jim ...

Ian Cleminson reported, As we move into 2025, the one thing that is going to be slightly different for us is that in 2024, we ...

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies -- outcomes not previously observed in SPS ...

Jamie Dimon’s 2026 letter outlines JPMorganChase’s record growth and strategic priorities regarding AI and global risk. Read the full analysis for more details.